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Background: Two studies evaluating the efficacy of an imidacloprid/flumethrin collar (SerestoW, Bayer Animal Health,
IVP), a deltamethrin collar (ScaliborW, MSD, CP1), a fipronil/(s)-methoprene spot-on (Frontline ComboW, Merial, CP2), a
dinotefuran/pyriproxyfen/permethrin spot-on (Vectra 3DW, Ceva, CP3) and an amitraz/fipronil/(s)-methoprene spot-on
(CertifectW, Merial, CP4/CP5) against repeated infestations with Rhipicephalus sanguineus and Ctenocephalides felis felis
on dogs were conducted over periods of 226 days and 71 days respectively.
Methods: The first study comprised 4 groups of treated dogs and one untreated control group, and the second 3
groups of treated dogs and one control group. Each group consisted of 8 dogs. All dogs were infested with ticks and
fleas at regular intervals. Ticks were counted 6 h, 18 h or 48 h after infestations and fleas 24 h after infestations.
Efficacies of the treatments were calculated by comparison with the untreated control groups using standard
descriptive statistics.
Results: The protective 48 h tick efficacy was 97.8% to 100% for the IVP (226 days), 69.3% to 97.4% for CP1 (170 days),
99.6% to 43.4% for CP2 (35 days) and 98% to 61.4% for CP3 (35 days).
The protective 18 h tick efficacy was 98% to 99.6% for the IVP (71 days), 100% to 86.5% for CP4 (29 days), 100% to
72.8% for CP4 after re-treatment (35 days) and 98.8% to 54.3% for CP5 (35 days).
The protective 6 h tick efficacy was 85.6% at Day 7 and 90.1% to 97.1% from Day 14 onwards for the IVP (70 days),
92.3% to 70.7% for CP4 (35 days), 97.5% to 65.2% for CP4 after re-treatment (35 days) and 95.1% to 51.8% for CP5
(35 days).
The protective 24 h flea efficacy was 99.5/90.9% to 100% for the IVP (71/226 days), 66.7% to 83% for CP1 (170 days),
100% to 88.5% for CP2 (35 days), 100% to 73.3% for CP3 (35 days), 100% to 98.7% for CP4 (35 days), 100% to 87.5% for
CP4 after re-treatment (35 days) and 100% to 79.5% for CP5 (35 days).* Correspondence: ivan.horak@up.ac.za
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http://www.parasitesandvectors.com/content/5/1/79Conclusions: These data suggest that the long-term efficacy provided by a medicated collar that is effective, is a
means to overcome the fluctuating efficacy of spot-on treatments resulting from a lack of pet owner re-treatment
compliance, and consequently protect animals successfully against ectoparasites and probably vector-borne
diseases.
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Ticks and fleas are parasites of dogs practically world-
wide. Although certain tick species are predominant on
dogs in some regions, the brown dog tick, Rhipicephalus
sanguineus is present on these animals in several regions
and predominant in others [1-3]. On the other hand the
cat flea, Ctenocephalides felis felis is widespread through-
out most regions, and infests both dogs and cats [4,5].
The effective control of these ectoparasites not only alle-
viates the immediate distress caused to their hosts, such
as itching, skin lesions and blood loss, but may also pre-
vent the direct effects of infestation such as tick-induced
paralysis and flea allergy dermatitis [6]. Furthermore, a
reduction in parasite numbers will inevitably have an
effect on the prevalence of the diseases that they transmit.
It is also possible that chemicals that have a repellent, or
a particularly rapid killing effect, could eliminate ticks
and fleas before they can transmit vector-borne organ-
isms with which they may be infected. For instance R.
sanguineus is a vector of Babesia canis, Babesia vogeli,
Babesia gibsoni, Hepatozoon canis and Ehrlichia canis,
the causative organisms of tick-borne diseases that
affect dogs in different regions of the world [7]. On the
other hand C. felis felis is the intermediate host of
the larval stage of the tapeworm Dipylidium caninum
of dogs and the vector of the bacterium Rickettsia
typhi, the organism responsible for murine typhus in
humans [8].
Several chemicals, or combinations of chemicals, with
acaricidal or insecticidal properties and which are appro-
priate and safe for treatment of domestic dogs and cats,
have been formulated for application either orally, paren-
tally, topically or as medicated collars [9,10]. Depending
on the active ingredients of the chemicals or combina-
tions of chemicals, they are effective against fleas or
ticks, or both [11,12], and may in addition also be suit-
able for the treatment of lice and mites [13,14]. Some of
these chemicals also have a persistent effect lasting for
several weeks after their initial application [12], while
others are effective for several months [15].
The aims of the present investigation were to evaluate
the efficacies of various remedies against ticks and fleas
on dogs. To this end two studies were performed during
which the efficacies of five chemicals or combinations
of chemicals were assessed against laboratory-inducedinfestations of R. sanguineus and C. felis felis. For the
sake of clarity the methods applicable to both studies
have been presented as an entity, and thereafter the
experimental designs and results of each study are
presented separately.
Methods: general
The studies were conducted in South Africa and were
parallel group-designed, randomised, unicentre, con-
trolled efficacy studies and were performed on groups of
eight dogs each. The dogs enrolled in the studies were
sub-adult and adult male and female mixed-breeds
weighing between 9.26 and 25.30 kg. They were main-
tained and handled with due regard for their welfare,
and were acclimatized to the kennel environment seven
to ten days prior to the commencement of the studies.
The dogs were individually housed in pens in animal
units that conformed to the South African National
Standards (SANS 10386:2008 The care and use of
animals for scientific purposes). Water was available
ad libitum and an adequate amount of a commercial
dog food towards their maintenance was provided
daily.
A laboratory-bred strain of R. sanguineus, originating
from France and subsequently maintained for at least
3 years on rabbits in South Africa, was used for infest-
ation of the dogs. Adult ticks used for infestation were
unfed, at least one week old, and of a balanced sex ratio
(50% female: 50% male). Each dog was infested with 50
ticks on the days indicated in the respective experimental
designs.
A laboratory-bred strain of C. felis felis, originating
from Hanover University, Germany, and maintained on
cats in South Africa for at least 2 years prior to the stud-
ies, was used for all infestations. Each dog was infested
with approximately 100 unfed fleas of mixed sex on the
days indicated in the respective experimental designs. At
the time of infestation neither the ticks nor the fleas
were placed near the collars, or on or near the site, or
sites, where the spot-on treatments were or had been
administered.
The time at which each animal was treated or at which
it was infested with ticks was recorded. This was done to
ensure that counting and removal of ticks were as close
as possible to the specified target times (6 h ± 30 min, or
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During the in situ counts, ticks were counted but not
removed. Ticks were found by direct observation follow-
ing parting of the hair coat and palpation over the whole
skin surface of the dog. The same procedure was fol-
lowed for the removal tick counts, but in addition the
dogs were combed after the ticks had been removed to
ensure that all ticks were found and counted. Ticks that
were removed were classified according to the para-
meters listed in Table 1.
The time at which each animal was treated or at
which it was infested with fleas was recorded. This
was done to ensure that counting was as close as
possible to the specified target times (48 ± 2 h post-
treatment or 24 ± 2 h post-infestation). During count-
ing a fine-toothed flea comb was used to recover
fleas from the animal’s hair. Combing was performed
by several strokes of the comb over each part of the
dog’s skin surface, each time in the same direction
and following the lie of the hair coat. Movement,
from one part of the animal’s body to the next, was
via strokes overlapping each other, so that no part of
the skin surface was missed. After the completion of
combing, the whole procedure was repeated so that
all areas were combed at least twice. If necessary a
third combing was performed until no live fleas were
found.
The pre-treatment flea counts of each dog were used
for ranking and group allocation purposes. The dogs
were ranked within gender, in descending order of indi-
vidual pre-treatment flea counts. Animal IDs were used
to break ties. Within each gender, animals were then
blocked and within each block dogs were randomly allo-
cated to the various treatment groups.
Efficacy against ticks and fleas was calculated for each
treatment group at each assessment day according to the
formulas below. All efficacy calculations were performed
on the arithmetic means of the tick or flea counts.
In accordance with the Guidelines for the testing and
evaluation of the efficacy of antiparasitic substances for
the treatment and prevention of tick and flea infestationTable 1 Classification of ticks on their state of attachment
and engorgement and whether they are alive or dead
Category Condition Attachment status
1 Alive Unattached
2 Alive Attached; unengorged*
3 Alive Attached; engorged**
4 Dead Unattached
5 Dead Attached; unengorged*
6 Dead Attached; engorged**
* no filling of the alloscutum evident.
** obvious or conspicuous filling of the alloscutum.in dogs and cats; EMEA/CVMP/005/2000- Rev.2: per-
cent efficacy for the in situ tick counts was calculated as
follows:
Efficacy %ð Þ ¼ 100x mc–mtð Þ=mc;where
mc = arithmetic mean number of live ticks (categories
1-3) on dogs in the untreated control group at a specific
time-point.
mt = arithmetic mean number of live ticks (categories
1-3) on dogs in the treated groups at a specific time-
point.
Percent efficacy for the removal tick counts was calcu-
lated as follows:
Efficacy %ð Þ ¼ 100x mc–mtð Þ=mc;where
mc = arithmetic mean number of live ticks (categories
1-3) on dogs in the untreated control group at a specific
time-point.
mt = arithmetic mean number of live and dead ticks
(categories 1-3 and 6) on dogs in the treated groups at a
specific time-point.
Percent efficacy against fleas was calculated as follows:
Efficacy %ð Þ ¼ 100x mc–mtð Þ=mc;where
mc = arithmetic mean number of live fleas on dogs in
the untreated control group
mt = arithmetic mean number of live fleas on dogs in
the treated groups.
Descriptive statistics (mean, minimum, maximum,
standard deviation, CV%, arithmetic mean and median)
on tick and flea counts on the various assessment days
were also performed. SAS Version 8 (Release 8.02 TS
Level 02 M0) was used for all the statistical analyses.
Methods: study 1
This study was designed to ascertain the immediate
and the long-term efficacy of a collar containing imi-
dacloprid 10% and flumethrin 4.5% (w/w) (SerestoW,
Bayer Animal Health) and a collar containing delta-
methrin 4% (w/w) (ScaliborW, MSD) against R. sangui-
neus and C. felis felis on groups of experimentally
infested dogs, compared to an untreated control
group of dogs infested with the same ectoparasites. In
addition a group of dogs treated with a spot-on for-
mulation of fipronil 10% (w/v) and (s)-methoprene 9%
(w/v) (Frontline ComboW, Merial), and another group
treated with a spot-on formulation of dinotefuran
4.95% (w/w), pyriproxyfen 0.44% (w/w) and permeth-
rin 36.08% (w/w) (Vectra 3DW, Ceva) were included
in the study 160 days after its commencement. Each
of the treated groups and the control group consisted
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occasions and examined for live parasites at predeter-
mined time intervals after infestation.
The medicated collars were fastened around the dogs’
necks and adjusted until a comfortable fit was achieved.
Excess collar was pulled through the collars’ loops and
any excess length beyond 2 cm was cut off. The fipronil/
(s)-methoprene spot-on formulation was administered at
a weight specific dosage of 0.067 ml/kg body weight and
applied as a single spot between the shoulder blades.
The spot-on formulation of dinotefuran/pyriproxyfen/
permethrin was administered at a dosage level of
0.14 ml/kg body weight. The calculated dose was applied
at three spots along the dog’s back, namely between the
shoulder blades, in the middle of the back and at the
base of the tail. The choice of dosage level, dose regimen
and of evaluation time-points will be dealt with more ex-
tensively in the discussion.
The experimental design of the study is summarized in
Table 2.Table 2 Experimental design of an ectoparasiticidal efficacy s
Ctenocephalides felis felis on dogs, Study 1
Study Day Activity
-6 24 dogs each infested with 100 fleas
-5 Fleas counted and flea numbers used for ranking and allocation
-1 Allocation to control group of 8 dogs (Group 1) and two treated









84 to 142 Infestation and counting at 4-weekly intervals the same as for Da
160 Two fresh groups of 8 dogs each (Groups 4 and 5) added to the
161 Infestation with fleas and ticks (Groups 1, 4 and 5), followed by s





170 End of label claim for Group 3, no further evaluation
175 to 198Infestation and counting at weekly intervals the same as for Days




* ticks and fleas counted 48 h after application of the collars.Methods: study 2
This study was designed to evaluate the immediate
and persistent “repellent” efficacies (measured at 6 h)
and “fast killing” efficacies (measured at 18 h) of a
collar containing imidacloprid 10.5% (w/w) and flume-
thrin 4.5% (w/w) (SerestoW, Bayer Animal Health)
against R. sanguineus and C. felis felis on dogs over a
period of 71 days. In addition it was so designed that
the immediate and persistent efficacy of a spot-on for-
mulation of (s)-methoprene 5.8%/amitraz 7.6%/fipronil
6.4% (w/v) (CertifectW, Merial) administered twice,
35 days apart, could be determined, and also so that
the efficacy of a single treatment with the latter rem-
edy on a group of dogs introduced into the study
35 days after its commencement could be determined.
The imidacloprid/flumethrin collars were fastened
around the dogs’ necks as previously described. The (s)-
methoprene/amitraz/fipronil combination was applied
topically on the skin of the neck between the base of the
skull and the shoulder blades as two spots oftudy against Rhipicephalus sanguineus and
to groups
groups (Groups 2, 3)
llaring
48 h flea and tick counts*
24 h flea, 48 h tick counts
7 to 9 above
24 h flea, 48 h tick counts
ys 56 to 58 above
study
pot-on treatment of dogs in groups 4 and 5.
and 5, thereafter dogs in all five groups subject to the same infestation
24 h flea, 48 h tick counts
168 to 170 above
24 h flea, 48 h tick counts
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0.107 ml/kg body weight. Exact weight dependent
dosages were chosen for the spot-on product to ensure
appropriate comparability with the collar and this will be
addressed in greater detail in the discussion.
The study was conducted in two phases. Phase 1 was
carried out on 24 dogs allocated to three groups and the
dogs in these groups also participated in Phase 2 of the
study. In Phase 2 eight fresh dogs were added to the
study 35 days after its commencement. The experimental
design of the study is summarized in Table 3.
Results
Results: study 1
Acaricidal (48 h) efficacy against R. sanguineus
The arithmetic mean tick counts of the untreated control
group of dogs 48 h after infestation varied between 23.6
and 38.4, thus ensuring a robust challenge with ticks on
all assessment days. The tick counts of the dogs in each
of the treatment groups are summarized in Table 4.
The mean tick counts recorded for the four treated
groups of dogs differed significantly (p< 0.05) from
those of the untreated control group of dogs (Group 1)
on all assessment days. The imidacloprid/flumethrin col-
lared dogs (Group 2) harboured significantly (p< 0.05)
fewer ticks 48 h after infestation on Days 58, 86 and 170
than the group of deltamethrin collared dogs (Group 3),
significantly (p< 0.05) fewer ticks on Day 198 than the
dogs treated with fipronil/(s) methoprene (Group 4), and
significantly (p< 0.05) fewer ticks on Days 191 and 198
than the dogs treated with dinotefuran/pyriproxyfen/
permethrin (Group 5).
The immediate efficacy of the various remedies against
ticks 48 h after treatment and persistent efficacy 48 h after
each re-infestation are graphically illustrated in Figure 1.Table 3 Experimental design of an ectoparasiticidal efficacy s
Ctenocephalides felis felis on dogs, Study 2
Study day Activity
-5 to -3 Flea infestation, counting and allocation to 3 groups of 8
0 Controls (Group 1) and treated dogs (Groups 2 and 3) infe
2
7 50 ticks, 100 fleas 6 h tick counts
8
14 to 29 Infestation and counting at weekly intervals the same as f
34 Fresh group of 8 dogs (Groups 4) added to study
35 Groups 1, 2 and 3 infested with fleas + ticks, Group 3 dogs
36 18 h tick counts and 24
42 (all groups) 50 ticks, 100 fleas 6 h tick counts
43
49 to 71 Infestation and counting at weekly intervals the same as fImmediate efficacies were similar on the imidacloprid/
flumethrin, deltamethrin, fipronil/(s)-methoprene and
dinotefuran/pyriproxyfen/permethrin treated groups of
dogs (78.3%, 86.5% 89.1% and 79.9%). Thereafter the per-
sistent efficacies of the imidacloprid/flumethrin collar
exceeded 97.8% until the termination of the study on
Day 226. Persistent, preventive acaricidal efficacies
recorded for this group of dogs were also consistently
higher than those recorded for the other treated groups
of dogs. With the exception of Days 16, 23 and 114 after
infestation, when efficacies above 90% were recorded for
the deltamethrin treated group of dogs, persistent effica-
cies for this group remained below the 90% level. Persist-
ent efficacies exceeding 90% lasted for four weeks on the
dogs treated with fipronil/(s)-methoprene, and for three
weeks on the dogs treated with dinotefuran/pyriproxy-
fen/permethrin whereafter efficacy decreased to 43.4%
for the fipronil/(s)-methoprene treated group and 61.4%
for the dinotefuran/pyriproxyfen/permethrin treated
group, five weeks after treatment.
Insecticidal (24 h) efficacy against C. felis felis
The arithmetic mean flea counts recorded for the un-
treated control group of dogs varied between 69.6 and
97.1, thus ensuring a robust flea challenge on all assess-
ment days. The mean flea counts of the dogs 48 h after
treatment and 24 h after each re-infestation are summar-
ized in Table 5.
The flea counts recorded for the four treated groups
of dogs differed significantly (p< 0.05) from those of
the untreated control group (Group 1) on all assess-
ment days. The imidacloprid/flumethrin collared
group of dogs (Group 2) had significantly (p< 0.05)
fewer fleas 24 h post-infestation than the deltamethrin
collared group of dogs (Group 3) on all assessmenttudy against Rhipicephalus sanguineus and
dogs (Groups 1, 2, 3)
sted with fleas and ticks, and treated directly thereafter (Groups 2 and 3)
48 h flea + tick counts
18 h tick counts 24 h flea counts
or Days 7 and 8 above
re-treated and Group 4 dogs treated for the first time directly thereafter
6 h tick counts (Groups 1, 2, and 3)
h flea counts (Groups 1, 2, and 3)
18 h tick counts 24 h flea counts
or Days 42 and 43 above
Table 4 Study 1: Mean numbers of ticks on treated dogs 48 h after treatment and 48 h after each re-infestation with
Rhipicephalus sanguineus











2* 28.8 6.3 3.9 - -
9 36.0 0.3 4.3 - -
16 33.9 0.8 0.9 - -
23 38.4 0.0 2.8 - -
30 33.4 0.1 3.4 - -
58 26.5 0.1 8.1 - -
86 31.1 0.3 8.3 - -
114 29.1 0.4 2.3 - -
142 33.3 0.0 5.9 - -
163 29.9 - - 3.3* 6.0*
170 31.3 0.0 5.1 0.1 0.6
177 33.1 0.1 - 0.5 1.5
184 32.8 0.1 - 2.4 2.8
191 34.1 0.3 - 2.5 5.5
198 23.6 0.0 - 13.4 9.1
226 29.4 0.4 - - -
* Flea counts 48 h after treatment.
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ences between the arithmetic mean numbers of fleas
on the imidacloprid/flumethrin collared, fipronil/(s)-
methoprene and dinotefuran/pyriproxyfen/permethrin


























Figure 1 Study 1. Efficacy of imidacloprid/flumeththrin and deltamethrin c
permethrin spot-on formulations against Rhipicephalus sanguineus on dogsThe immediate efficacy of the various remedies against
fleas 48 h after treatment and persistent efficacy 24 h
after each re-infestation are graphically illustrated in
Figure 2.
The immediate efficacy of the imidacloprid/flumethrin
collar against C. felis felis 48 h after collaring was 99.8%,4 142 163 170 177 184 191 198 226
dy Day




ollars, and fipronil/(s) methoprene and dinotefuran/pyriproxyfen/
48 h after treatment and 48 h after each re-infestation.
Table 5 Study 1: Mean numbers of fleas on treated dogs 48 h after treatment and 24 h after each re-infestation with
Ctenocephalides felis felis











2* 70.4 0.1 21.4 - -
9 70.1 0.0 15.3 - -
16 78.8 0.0 21.1 - -
23 80.0 0.0 14.3 - -
30 83.8 0.0 17.9 - -
58 69.6 0.0 13.9 - -
86 72.0 0.0 19.5 - -
114 72.5 0.3 24.1 - -
142 72.3 0.4 16.4 - -
163 72.5 - - 0.0* 0.0*
170 78.0 2.8 13.3 0.0 0.0
177 88.8 6.0 - 0.0 2.0
184 89.1 2.3 - 0.0 1.1
191 91.4 5.0 - 1.4 13.3
198 97.1 8.9 - 11.1 25.5
226 82.6 5.9 -
* Flea counts 48 h after treatment.
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93.2% was recorded, persistent efficacies, assessed 24 h
after each re-infestation, varied between 94.5% and 100%
until Day 191, decreasing thereafter to 90.9% and 92.9%
on Days 198 and 226 respectively. The immediate effi-

























Figure 2 Study 1. Efficacy of imidacloprid/flumeththrin and deltamethrin c
permethrin spot-on formulations against Ctenocephalides felis felis on dogs48 h after collaring, was 69.6%, and persistent efficacies,
assessed 24 h after each re-infestation, varied between a
low of 66.7% on Day 114 and a high of 83.0% on Day
170. The spot-on treatments with fipronil/(s) metho-
prene and dinotefuran/pyriproxyfen/permethrin resulted






ollars, and fipronil/(s) methoprene and dinotefuran/pyriproxyfen/
48 h after treatment and 24 h after each re-infestation.
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fipronil/(s) methoprene treated group of dogs and three
weeks on the dinotefuran/pyriproxyfen/permethrin
group of dogs, thereafter efficacy decreased to 88.5% for
the fipronil/(s)-methoprene treated group and 73.7% for
the dinotefuran/pyriproxyfen/permethrin treated group,
five weeks post treatment.
Results: study 2
“Fast killing” acaricidal (18 h) efficacy against R. sanguineus
The arithmetic mean numbers of ticks counted on dogs
in the untreated control group 18 h after infestation var-
ied between 20.5 and 36.9, thus ensuring a robust tick
challenge on all assessment days. The tick counts of the
dogs in each of the treatment groups are summarized in
Table 6.
The mean tick counts recorded 18 h after infestation
for all treated groups of dogs (Groups 2, 3 and 4) dif-
fered significantly (p< 0.05) from those of the untreated
control group (Group 1) on all assessment days. The
mean tick counts recorded for the imidacloprid/
flumethrin treated group were significantly (p< 0.05)
lower on Days 29, 64 and 71 than those of the group
treated twice with (s)-methoprene/amitraz/fipronil, and
also significantly lower on Days 57, 64 and 71 than those
of the group of dogs treated for the first time on Day 35.
The immediate efficacy of the various remedies against
ticks 48 h after treatment and persistent efficacy 18 h
after each re-infestation are graphically illustrated in
Figure 3.
The immediate efficacy of (s)-methoprene/amitraz/
fipronil against ticks was markedly superior to that
recorded for the imidacloprid/flumethrin collars. However,
persistent fast-killing efficacies for the imidacloprid/Table 6 Study 2: Mean numbers of ticks on treated dogs 48 h
Rhipicephalus sanguineus







2* 20.5 4.5 1.6
8 25.4 0.3 0.0
15 30.9 0.1 0.6
22 31.5 0.1 1.9
29 34.4 0.3 4.6
36 34.9 0.4 0.5
43 32.1 0.4 0.0
50 33.6 0.1 1.0
57 35.8 0.4 2.5
64 36.9 0.8 5.8
71 33.1 0.1 9.0
* Tick counts 48 h after treatment.
** Tick counts 18 h after re-treatment.flumethrin collars assessed 18 h post-infestation was≥ 98%
for the duration of the study, whereas persistent efficacy
on the dogs treated twice with (s)-methoprene/amitraz/
fipronil exceeded 90% on Days 8, 15 and 22 after the first
treatment and on the same days after the second treat-
ment. Persistent tick efficacy on the group of dogs treated
with (s)-methoprene/amitraz/fipronil for the first time on
Day 35 exceeded 90% in the first two weeks after treat-
ment (Days 43 and 50).
“Repellent” or acaricidal (6 h) efficacy against R. sanguineus
The arithmetic mean tick counts recorded on the dogs
in the untreated control group 6 h after infestation var-
ied between 27.8 and 36.9, thus ensuring a robust tick
challenge on all assessment days. The mean tick counts
of the dogs in the different treatment groups are sum-
marized in Table 7.
The tick counts of the dogs in each of the treated
groups 6 h after infestation differed significantly (p
< 0.05) from those of the untreated control group on all
assessment days. The tick counts of the dogs in the imi-
dacloprid/flumethrin treated group were significantly (p
< 0.05) lower on Days 28, 56, 67 and 70 than those of
the dogs treated twice with (s)-methoprene/amitraz/
fipronil, and also significantly (p< 0.05) lower on Days
49, 56, 63 and 70 than those of the dogs in the group
treated for the first time on Day 35.
The efficacies of the various treatments against ticks
6 h after each infestation are graphically illustrated in
Figure 4.
Except for Days 7 and 42, the persistent efficacies
against R. sanguineus recorded 6 h after infestation
on the group of dogs fitted with imidacloprid/flume-
thrin collars were consistently higher than those ofafter treatment and 18 h after each re-infestation with
-methoprene/amitraz/fipronil

































Rhipicephalus sanguineus (18 h after each infestation)
Imidacloprid/flumethrin
(S)-methoprene/amitraz/fipronil Days 0 and 35
(S)-methoprene/amitraz/fipronil Day 35
Figure 3 Study 2. Efficacy of an imidacloprid/flumeththrin collar and a (s) –methoprene/amitraz/fipronil spot-on formulation against
Rhipicephalus sanguineus on dogs 48 h after treatment and 18 h after each re-infestation.
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methoprene/amitraz/fipronil.
Insecticidal (24 h) efficacy against C. felis felis
The arithmetic mean flea counts of the untreated control
group of dogs varied between 69.3 and 85.4, thus ensur-
ing a robust challenge with fleas on all assessment days.
The mean flea counts of the dogs in each of the treat-
ment groups are summarized in Table 8.
The flea counts of the dogs in the treated groups dif-
fered significantly (p< 0.05) from those of the untreated
control group of dogs (Group 1) on all assessment days.
No significant differences (p> 0.05) in the mean flea
counts of dogs treated with the imidacloprid/flumethrinTable 7 Study 2: Mean numbers of ticks on treated dogs 6 h







7 27.8 4.0 2.1
14 32.9 2.3 5.8
21 32.4 1.8 7.4
28 34.1 1.4 10.
35 36.9 1.1 4.0
42 30.4 0.9 0.8
49 34.6 1.9 4.4
56 35.3 3.5 8.1
63 36.9 2.5 10.
70 35.3 1.4 12.
* Tick count 6 h after re-treatment.collars (Group 2) and treated twice with the metho-
prene/amitraz/fipronil formulation (Group 3) were
observed. The mean flea counts on Day 71 of dogs in the
group fitted with imidacloprid/flumethrin collars were
significantly (p< 0.05) lower than those of the dogs trea-
ted for the first time on Day 35 with (s)-methoprene/
amitraz/fipronil (Group 4).
Efficacy values derived from the 24 h flea counts are
graphically illustrated in Figure 5.
Immediate efficacies against fleas recorded for both
treatment groups on Day 2 were similar. Persistent
efficacies assessed 24 h after re-infestation exceeded
98% in all treated groups up to Day 57. However, ef-
ficacy in the group of dogs treated twice with (s)-after each infestation with Rhipicephalus sanguineus
-methoprene/amitraz/fipronil
































Rhipicephalus sanguineus (6 h after each infestation)
Imidacloprid/flumethrin
(S)-methoprene/amitraz/fipronil Day 0 and Day 35
(S)-methoprene/amitraz/fipronil  Day 35
Figure 4 Study 2. Efficacy of an imidacloprid/flumeththrin collar and a (s) –methoprene/amitraz/fipronil spot-on formulation against
Rhipicephalus sanguineus on dogs 6 h after each infestation.
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Day 64 (4 weeks after re-treatment) to 87.5% a week
later. Efficacy in the group of dogs treated for the
first time on Day 35 declined to 91.9% by Day 64
(4 weeks after treatment) and 79.5% a week later.
Persistent efficacy in the imidacloprid/flumethrin
treated group exceeded 99% for the duration of the
study.Table 8 Study 2: Mean numbers of fleas on treated dogs 48 h
Ctenocephalides felis felis







2* 75.3 0.3 0.5
8 69.3 0.0 0.0
15 83.4 0.0 0.1
22 80.9 0.0 0.5
29 85.4 0.0 1.1
36 73.9 0.4 0.0
43 75.0 0.0 0.0
50 74.1 0.0 0.1
57 75.8 0.1 0.8
64 72.5 0.0 1.0
71 85.3 0.4 10.
* flea counts 48 h after treatment.
** flea counts 24 h after re-treatment.Discussion
Discussion of study design
When conducting a study comparing the long-term acar-
icidal efficacy of collars against that of the medium-term
efficacy of spot-on products, a number of difficulties
arise. These are related to the nature of the remedies,
the choice of treatment, the evaluation time-points and
the choice of the dose regimen.after treatment and 24 h after each re-infestation with
-methoprene/amitraz/fipronil

































Ctenocephalides felis felis (24 h after each infestation)
Imidacloprid/flumethrin
(S)-methoprene/amitraz/fipronil Days 0 and 35
(S)-methoprene/amitraz/fipronil Day 35
Figure 5 Study 2. Efficacy of an imidacloprid/flumeththrin collar and a (s) –methoprene/amitraz/fipronil spot-on formulation against
Ctenocephalides felis felis on dogs 48 h after treatment and 24 h after each re-infestation.
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time-points The aim of the study was to give an ex-
perimentally-based assessment of the performance
over time of a variety of remedies that are available
for the treatment and control of ticks and fleas on
dogs. Because of the difficulties listed above, a
straightforward, direct comparison embracing all treat-
ments and starting on Day 0 would not result in an
ideal outcome. However, as both the imidacloprid/
flumethrin and the deltamethrin collars claim long-
term efficacy of 8 months and 6 months respectively,
the decision was taken to start simultaneous treat-
ment with them on Day 0 of Study 1. In addition,
because the imidacloprid/flumethrin collar claims effi-
cacy lasting 8 months it would only be fair to com-
pare its efficacy towards the end of this period of
time with that of freshly applied spot-on treatments
that claim efficacy of four weeks. Consequently treatment
with the two spot-on products included in Study 1 was
only administered on Day 161 (5 months+ 11 days into
the study). This allowed for a comparison of efficacy be-
tween the imidacloprid/flumethrin collar towards the end
of its claimed period of efficacy and those of the two spot-
on treatments applied during this time.
The investigative periods for the imidacloprid/
flumethrin and the deltamethrin collars comprised the
length of time claimed for their respective efficacies. In
contrast the investigative periods for the spot-on pro-
ducts was increased by one week beyond their claimed4-week period of efficacy. This was done to assess the
persistent effectiveness of the spot-on treatments should
a pet owner decide to extend the period between treat-
ments by a week because of a reliance on the assumed
slow decrease in efficacy of these remedies. The latter
practice can, however, result in unwanted gaps in
efficacy.
The choice of treatment time-points for Study 2 fol-
lowed a similar rationale. The (s)-methoprene/amitraz/
fipronil spot-on and the imidacloprid/flumethrin collar
were directly compared from Day 0 and onwards. Then
on Day 35, subsequent to the claimed period of efficacy
of the spot-on formulation, the same group of dogs was
re-treated with the same remedy. This was done to de-
termine whether regular re-treatment would enhance the
performance of the spot-on product, and also so that the
effectiveness of multiple treatments with the spot-on for-
mulation could be compared with a single application of
the collar formulation.
The efficacy claim for the (s)-methoprene/amitraz/
fipronil spot-on is 4 weeks, however, its efficacy against
ticks and fleas is said to be 5 weeks according to the pro-
duct’s SPC and package leaflet, namely one treatment
prevents further infestation for 5 weeks by ticks and for up
to 5 weeks by fleas. On Day 35 a second (s)-methoprene/
amitraz/fipronil spot-on treated group of dogs was en-
rolled. This was done so that the efficacy of this spot-on
treatment could be compared with that of the collar
that had already been in place for 35 days and also
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administered to the dogs that had been treated 35 days
previously. If re-treatment enhanced the efficacy of
the spot-on formulation, a series of regular re-
treatments would be a more appropriate comparison
with the long-term efficacy of the collars.
Infestation and evaluation time-points The infest-
ation and evaluation time-points in Study 1 were
chosen in accordance with the products’ label claims
and the Guidelines for the testing and evaluation of
the efficacy of antiparasitic substances for the treat-
ment and prevention of tick and flea infestation in
dogs and cats; EMEA/CVMP/005/2000- Rev.2 and
current regulatory practice regarding efficacy evalu-
ation, namely flea counts after 24 h and tick counts
after 48 h. Because the efficacies against ticks of the
remedies under evaluation in Study 2 were expected
to be similar at the 48 h assessment time-points, the
choice of the tick counting time-point was based on
data already published on the efficacy of the (s)-
methoprene/amitraz/fipronil spot-on [16], namely
“rapid killing” (18 h post-infestation) or “repellence”
(6 h post-infestation).
Dosage Exact weight dependent dosages were chosen
for the spot-on remedies as this neutralizes the influence
of different animal sizes and body weights in a relatively
limited sample size, thus making an equitable compari-
son between spot-on remedies possible. In spot-on for-
mulations the total amount of active ingredient, or
ingredients, are immediately released on the treated ani-
mal’s skin. This is not so with collar formulations, which
rely on the slow-release of active ingredients. Conse-
quently a weight range dosage level was chosen for the
collars, which were carefully adjusted to fit each dog’s
neck circumference, and any excess length cut off. The
release of active ingredients from the collar is, at least in
the case of the imidacloprid/flumethrin collar, a “release
on demand” and is therefore nearly directly animal-
surface and consequently size related. Thus correctly
applied imidacloprid/flumethrin collars deliver a daily
active ingredient dosage level that is close to being
weight dependent [17]. Furthermore, the daily dosage
levels calculated from the release-values over 8 months
were found to be comparable for dogs and cats of differ-
ent sizes [17].
Discussion of results
The efficacy of the imidacloprid/flumethrin collars
against R. sanguineus and C. felis felis, weeks or even
months after their application, was as high as that
recorded initially for three spot-on formulations admi-
nistered to separate groups of dogs either at the sametime as the collars, or 5 weeks or 5½months after the
collars had been applied. Furthermore, while the effica-
cies of the spot-on formulations generally decreased dur-
ing the successive weeks following their application,
those of the imidacloprid/flumethrin collars persisted at
the same high level. The decrease in efficacy of the spot-
on treatments five weeks after their application indicates
that re-treatment subsequent to their 4-week claims of
effectiveness is advisable. A second treatment with the
(s)-methoprene/amitraz/fipronil spot-on formulation did
not enhance or prolong its efficacy during the ensuing
evaluation period.
Although the immediate acaricidal efficacy of the imi-
dacloprid/flumethrin collars against R. sanguineus at the
start of the study (Day 2) was below 90% in the two
studies reported here, it equalled or exceeded 78%. With
the exception of these results, the persistent acaricidal
preventative efficacy of these collars either significantly
or noticeably exceeded that of the deltamethrin collars at
each assessment time-point. On most occasions persist-
ent efficacy also exceeded those of the spot-on formula-
tions of fipronil/(s)-methoprene and dinotefuran/
pyriproxyfen/permethrin, as well as those measured 18 h
after infestation, for the (s)-methoprene/amitraz/fipronil
spot-on formulation.
Unexpectedly, considerable variation in the acaricidal
effectiveness of the deltamethrin collar between individ-
ual dogs was observed. This variability contributed to the
overall lower than anticipated efficacy of this collar com-
pared to published results on its effectiveness 48 h after
re-infestation [18]. In contrast there appeared to be no
marked variability in the efficacy of the imidacloprid/
flumethrin collars in the present and other studies
[19,20].
Repellent effects are a general property of pyrethroids.
Their in-contact efficacy comprises a mixture of a very
rapid lethal effect, a knock down effect and the so-called
“hot-foot effect”, instead of a vapour-based classical
repellent effect. Besides the well-described difference of
specific ectoparasiticidal potency amongst different pyre-
throids of even the same chemical subclass [e.g. Mendes
[21] described a 125-fold and 400-fold higher efficacy
(EC50 after 5 min contact) of flumethrin on Boophilus
microplus than deltamethrin and cyfluthrin, respectively],
the expression of efficacy can also vary within the same
molecule. There is a dose-time-dependency for lethal
effects in pyrethroids [22] so that the presence of a very
fast acaricidal “repellent” effect is perhaps an indication
for higher doses on the hair coat when compared to the
dose of the same pyrethroid that only results in an acari-
cidal effect 48 h after its application. In the case of the
deltamethrin collar, for which 24 h efficacy against ticks
does not exceed the 90% threshold [18], the hair coat
concentration of deltamethrin released by the collar is
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efficacy. In contrast the hair coat concentrations after ap-
plication of the imidacloprid/flumethrin collar obviously
exceed the critical dose required to achieve 18 h and
even 6 h efficacy. This suggests that the 48 h acaricidal
efficacy of the latter collar is backed by a resilient safety
margin of active ingredient on the animal’s hair coat.
The long-term repellent efficacy of the imidacloprid/
flumethrin collars in Study 2, measured 6 h after infest-
ation with R. sanguineus, was, with the exception of Day
7 after treatment, above 90%, followed by “rapid killing”
acaricidal efficacies ≥98% against the same population of
ticks 12 h later (Tables 6 and 7). With the exception of
Days 7 and 42, when the 6 h repellent efficacy of the (s)-
methoprene/amitraz/fipronil spot-on treatment exceeded
that of the collars, and Days 8 and 43 when the 18 h
“rapid killing” efficacy of the spot-on treatment exceeded
that of the collars, the effectiveness of the collars
exceeded that of the spot-on formulation. The rapidity
with which ticks are killed by the active ingredients of
the collars and the spot-on treatment, implies that there
might be significant interference with the transmission of
tick-borne organisms.
The excellent immediate and medium-term efficacies of
the spot-on formulations of (s)-methoprene/fipronil, dinote-
furan/pyriproxyfen/permethrin and (s)-methoprene/ami-
traz/fipronil against C. felis felis makes them suitable
candidates for the immediate and medium-term control of
fleas and hence also flea allergic dermatitis on dogs [6]. In
addition to its immediate high efficacy against fleas, the ap-
proximately 8-month long persistent efficacy of the imida-
cloprid/flumethrin collar should control fleas for the whole
flea season from late winter to autumn. The collars could
thus also constitute an important component in the multi-
remedy regimen required for the treatment and prevention
of flea allergy dermatitis during the entire season of flea ac-
tivity [6].
Although the effectiveness of the various remedies
tested in these studies may at various stages after their
application be excellent, it is the number of living ticks
or fleas remaining on treated dogs, when efficacy
decreases or is poor, that are important. Tick burdens
exceeding 10 individuals after treatment are quite ad-
equate for the transmission or acquisition of organisms
responsible for tick-borne diseases in the field, while a
few fleas remaining after ineffective treatment are cap-
able of inducing severe signs of flea allergy dermatitis.
This implies that if pet owners do not comply with the
recommended time-periods between the administration
of spot-on remedies serious gaps in efficacy may occur.
The long-term, persistently high efficacy of the imidaclo-
prid/flumetrin collars would appear to be an excellent
counter to these eventualities.The studies above were all laboratory based, while
in the field various challenges to the efficacy of the
medicated collars may occur. The most obvious of
these is that dogs are inevitably going to be washed
or shampooed, or swim or go out into the rain while
being walked by their owners or working in the field.
Importantly collars do not have to be removed during
any of these events [20], and that their efficacy against
re-infestation with R. sanguineus remained above 97%
over a period of 8 months on regularly shampooed
dogs, and above 94% on dogs regularly immersed in
water. Efficacy against C. felis felis remained above
90% on shampooed dogs for the 8-month duration of
the study, but declined to below 90% at 6 months in
the group of dogs that were regularly immersed in
water [20].
Conclusions
The 8-month long period of efficacy of medicated col-
lars incorporating a combination of 10% imidacloprid
and 4.5% flumethrin against repeated infestations of
Rhipicephalus sanguineus and Ctenocephalides felis
felis on dogs, provides the wherewithal to overcome
the fluctuating medium-term efficacy of spot-on treat-
ments resulting from a lack of pet owner re-treatment
compliance. The sustained high level of efficacy of the
collars against ticks 6 hours and fleas 24 hours after
infestation, may well interfere with the transmission
of vector-borne diseases.
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